Global Medical REIT (GMRE) to Release Quarterly Earnings on Wednesday

Global Medical REIT (NYSE:GMRE) is projected to release its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect Global Medical REIT to post earnings of $1.02 per share and revenue of $37.4420 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 26, 2026 at 9:00 AM ET.

Global Medical REIT Price Performance

GMRE opened at $36.59 on Wednesday. The company has a quick ratio of 0.52, a current ratio of 0.52 and a debt-to-equity ratio of 1.65. The company’s 50-day moving average price is $35.11 and its 200 day moving average price is $34.25. Global Medical REIT has a fifty-two week low of $29.05 and a fifty-two week high of $45.75. The firm has a market cap of $490.54 million, a price-to-earnings ratio of -146.35 and a beta of 1.18.

Global Medical REIT Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, January 9th. Shareholders of record on Friday, December 19th were paid a $0.75 dividend. The ex-dividend date was Friday, December 19th. This represents a $3.00 annualized dividend and a dividend yield of 8.2%. Global Medical REIT’s dividend payout ratio (DPR) is presently -1,200.00%.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on GMRE shares. Robert W. Baird reduced their price target on Global Medical REIT from $45.00 to $41.00 and set a “neutral” rating for the company in a research report on Tuesday, November 11th. Wall Street Zen downgraded shares of Global Medical REIT from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. Finally, Weiss Ratings raised shares of Global Medical REIT from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, January 21st. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $42.00.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Caitong International Asset Management Co. Ltd increased its holdings in shares of Global Medical REIT by 1,001.4% in the third quarter. Caitong International Asset Management Co. Ltd now owns 793 shares of the company’s stock valued at $27,000 after buying an additional 721 shares in the last quarter. Tower Research Capital LLC TRC grew its holdings in shares of Global Medical REIT by 70.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 7,379 shares of the company’s stock worth $51,000 after acquiring an additional 3,046 shares during the last quarter. B. Riley Wealth Advisors Inc. acquired a new stake in shares of Global Medical REIT during the second quarter worth $78,000. Virtus Advisers LLC lifted its holdings in shares of Global Medical REIT by 46.5% during the fourth quarter. Virtus Advisers LLC now owns 2,418 shares of the company’s stock valued at $82,000 after purchasing an additional 768 shares during the last quarter. Finally, State of Wyoming lifted its holdings in shares of Global Medical REIT by 71.3% during the second quarter. State of Wyoming now owns 12,656 shares of the company’s stock valued at $88,000 after purchasing an additional 5,266 shares during the last quarter. Institutional investors and hedge funds own 57.52% of the company’s stock.

Global Medical REIT Company Profile

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.